EBS_EU_Health_02_RGB_24

European Health Summit 2024

03 & 04 December

Egmont Palace, Brussels

On the theme “Gold Medal Mindset: Competitiveness and Sustainability in the Tech Age”, the Summit will provide a privileged platform to shape the healthcare agenda of the EU for the next legislative cycle and work towards a resilient healthcare model in the EU. Together with prominent representatives of civil society and the academic world, the business community will directly engage with policymakers to debate key healthcare issues in Europe and beyond, such as digital acceleration, pandemic preparedness, pharmaceutical industrial policy and optimising patient-centricity.

Meet the speakers

Hans Kluge
Regional Director Europe, WHO
Sandra Gallina
Director-General, DG SANTE
Kurt Vandenberghe
Director-General, DG CLIMA
Laurent Muschel
Acting Director-General, DG HERA
Emer Cooke
Executive Director, European Medicines Agency
Peter Takács
State Secretary for Health, Government of Hungary
Adonis Georgiadis
Minister for Health, Government of Greece
Izabela Leszczyna
Minister for Health, Government of Poland
Hosam Abu Meri
Minister for Health, Government of Latvia
Acko Ankarberg Johansson
Minister of Health Care, Government of Sweden
Michael Damianos
Minister for Health, Government of Cyprus
Thomas Östros
Vice President, European Investment Bank
Jonathan Symonds
Non-Executive Chair, GSK
Shikha Pillai
Chief Sustainability Officer, Siemens Healthineers
Hubert Gambs
Deputy Director-General, DG GROW
Sebastian Guth
Chief Operating Officer of Bayer Pharmaceuticals, President of Bayer U.S.
Carlton Lawson
President of Europe, Kenvue
Iris Zemzoum
President Europe, Novartis
Katrin Pucknat
Chief Marketing Officer, ResMed
Hans Henrik Knudsen
CEO, Kvantify
Jean-Marc Bourez
Chief Executive Officer, EIT Health
Karl Broich
President, Federal Institute for Drugs and Medical Devices of Germany
Massimo Giorgio Visentin
Eastern Europe Cluster President, Pfizer
Lene Oddershede
Senior Vice President, Professor, Novo Nordisk Foundation
Thomas Senderovitz
Senior Vice President Data Science, Novo Nordisk
Gilles Marrache
Senior Vice President for the ELMAC Region, Amgen
Stefan Woxström
Senior Vice President of Europe and Canada, AstraZeneca
Antonella Cardone
CEO, European Patients Europe
Jeffrey Francer
Vice President, Global Regulatory Affairs Policy, Eli Lilly
Aris Prins
President, Pharmaceutical Group of the European Union (PGEU)
Hatice Beton
Executive Director, G20&G7 Health and Development Partnerships
Cecilia Bonefeld-Dahl
Director-General of DIGITALEUROPE
Marta Temido
Member of the European Parliament
Padraic Ward
Head of Pharma International, Roche
Irene Norstedt
Director for People, Health & Society, DG RTD
Antonio Parenti
Director for Public Health, Cancer and Health Security, DG SANTE
Géraldine Mahieu
Director for Investment, Growth & Structural Reforms, DG ECFIN
Josep Figueras
Director and Cofounder, European Observatory on Health Systems and Policies
Núria Mas
Associate Dean for Faculty and member of the Executive Committee, IESE Business School
Sabrina Maniscalco
Professor of Quantum Information, Computing and Logic, University of Helsinki
Anke van Es
Head of Hospital Patient Monitoring, Europe, Philips
Giancarlo Benelli
Head RadioLigand Therapy International, Novartis
Malina Müller
Head of Health Economics, WifOR institute
Christoph Schöbel
Head of the Center for Sleep and Telemedicine at the Ruhrlandklinik, Essen University Medical Center
Matthias Christandl
Chairman, Steering Group of UCPH Quantum Hub
Gemma Solomon
Professor, Department of Chemistry, University of Copenhagen
Mellie Laursen
Founder of LinKS
Erna S. Arnardóttir
Secretary, European Sleep Research Society
Jennifer Baker
EU Reporter
Sarah-Taïssir Bencharif
EU Health Journalist
Jacki Davis
Meade Davis Communications Reporter
Andy Bounds
Financial Times Correspondent
Felicia Balan
Health Project Director, European Business Summits
Arnaud Thysen
Director General, European Business Summits

“We need to have long-term sustainability of the budget: demographically we will have an increase in certain health needs. Therefore, we need the industry to provide us with innovative technologies.”

Sandra Gallina
Director General DG SANTE, European Commission

“It’s important to acknowledge that our industry is global and it’s built on knowledge. We must ensure that Europeans have access to innovation.”

Lars Fruergaard Jørgensen
CEO of Novo Nordisk, President of EFPIA

“Most of the innovation is generated in the US, not in Europe. For the patients, this is a matter of access to science and clinical trials. So not having clinical trials in Europe is a huge problem.”

Antonella Cardone
CEO, Cancer Patients Europe

Check the 2024 Agenda

Our mission statement

Our mission is twofold: we aim to bring politics and business together in order to provide them with an opportunity to debate and pursue their common goals, giving a voice to all sides of the debate. The other priority of EBS is to provide European institutions with a platform where they can place their top priorities in the spotlight and advance the development of new pieces of legislation through discussion with a variety of actors and stakeholders.

Arnaud Thysen
Director General

They trust us

Among other: